Search for a funded project
Immune response during Covid19 infection – CovImmune
Europe has been facing the outbreak of the new coronavirus disease 2019 (COVID-19). This highly contagious [...] zoonosis caused by a virus SARS-CoV-2 from the coronavirus family that emerged in Wuhan in Chine in November
Implementation of a fast and reliable assay for the high-throughput screening of antiviral molecules active against SARS-CoV-2 – Alpha-COV
Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented pandemic termed Covid-19 (Coronavirus disease
Study of immune crosstalk in COVID-19 – COVIMUNE
Coronavirus disease 2019 (COVID-19) is caused by "severe acute respiratory syndrome coronavirus 2" (
Prospective analysis of morbi-mortality of patients with cancers in active phase of medical treatment suspected or diagnosed of a SARS-COV2 infection. – ONCOVID-19
Since December 2019, the novel coronavirus (SRAS-COV2, causing an emerging infectious disease called [...] clinical outcome of patients with a suspected coronavirus infection (either confirmed or not) while receiving
Interventions for Covid-19 infection: a living mapping of research and a series of living network meta-analyses – living-NMA-covid
Context: In December 2019, a novel coronavirus outbreak was documented in Wuhan, Hubei Province, China [...] first 6 weeks of the new decade, this novel coronavirus, known as SARS-CoV-2, has spread from China to
Social distancing and pro-sociality in times of acute sanitary crisis – DISTANCING
the epidemic”. Context. To stop the current coronavirus pandemic, the governments of most developed countries [...] Our objective is to study whether the ongoing coronavirus pandemic (COVID-19) and the massive and drastic
Household transmission investigation study for SARS-CoV-2 in French Guiana – EPI-COVID-19
Since December 2019, a new coronavirus, SARS-CoV-2, has been identified in the city of Wuhan in China
Regulating Wetmarkets in Central China : Ethnographic Study of the Perception of Zoonotic Risks after the Covid-19 Crisis – RegWet
which was the epicenter of emergence of this new coronavirus transmitted from bats to animals sold for human
Developing a new viro-fluidic technology to explore the viral production from infected cells in real-time at the single-cell and single-particle levels – virofluidics
adaptable to other pandemic viruses such as Coronavirus (SARS-CoV-2) and Hepatitis E virus which are
COVID 19 Rapid diagnosis test (development and clinical validation in 7 weeks) – CORaDiag
an acute respiratory disease caused by novel coronavirus SARS-CoV-2 also known as 2019-nCoV. On March